Table of Content

1 Market Overview of Monoclonal Antibody Drug
1.1 Monoclonal Antibody Drug Market Overview
1.1.1 Monoclonal Antibody Drug Product Scope
1.1.2 Monoclonal Antibody Drug Market Status and Outlook
1.2 Global Monoclonal Antibody Drug Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Monoclonal Antibody Drug Market Size by Region (2024-2034)
1.4 Global Monoclonal Antibody Drug Historic Market Size by Region (2024-2024)
1.5 Global Monoclonal Antibody Drug Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Monoclonal Antibody Drug Market Size (2024-2034)
1.6.1 North America Monoclonal Antibody Drug Market Size (2024-2034)
1.6.2 Europe Monoclonal Antibody Drug Market Size (2024-2034)
1.6.3 Asia-Pacific Monoclonal Antibody Drug Market Size (2024-2034)
1.6.4 Latin America Monoclonal Antibody Drug Market Size (2024-2034)
1.6.5 Middle East & Africa Monoclonal Antibody Drug Market Size (2024-2034)
2 Monoclonal Antibody Drug Market by Type
2.1 Introduction
2.1.1 Humanized Monoclonal Antibody Drugs
2.1.2 Fully Human Monoclonal Antibody Drugs
2.1.3 Small Molecule Antibody Drugs
2.1.4 Chimeric Monoclonal Antibody Drugs
2.1.5 Other
2.2 Global Monoclonal Antibody Drug Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Monoclonal Antibody Drug Historic Market Size by Type (2024-2024)
2.2.2 Global Monoclonal Antibody Drug Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Monoclonal Antibody Drug Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Monoclonal Antibody Drug Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Monoclonal Antibody Drug Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Monoclonal Antibody Drug Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Monoclonal Antibody Drug Revenue Breakdown by Type (2024-2034)
3 Monoclonal Antibody Drug Market Overview by Application
3.1 Introduction
3.1.1 Cancer Treatment
3.1.2 Autoimmune Disease Treatment
3.2 Global Monoclonal Antibody Drug Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Monoclonal Antibody Drug Historic Market Size by Application (2024-2024)
3.2.2 Global Monoclonal Antibody Drug Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Monoclonal Antibody Drug Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Monoclonal Antibody Drug Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Monoclonal Antibody Drug Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Monoclonal Antibody Drug Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Monoclonal Antibody Drug Revenue Breakdown by Application (2024-2034)
4 Monoclonal Antibody Drug Competition Analysis by Players
4.1 Global Monoclonal Antibody Drug Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Monoclonal Antibody Drug as of 2022)
4.3 Date of Key Players Enter into Monoclonal Antibody Drug Market
4.4 Global Top Players Monoclonal Antibody Drug Headquarters and Area Served
4.5 Key Players Monoclonal Antibody Drug Product Solution and Service
4.6 Competitive Status
4.6.1 Monoclonal Antibody Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott
5.1.1 Abbott Profile
5.1.2 Abbott Main Business
5.1.3 Abbott Monoclonal Antibody Drug Products, Services and Solutions
5.1.4 Abbott Monoclonal Antibody Drug Revenue (US$ Million) & (2024-2024)
5.1.5 Abbott Recent Developments
5.2 Johnson & Johnson
5.2.1 Johnson & Johnson Profile
5.2.2 Johnson & Johnson Main Business
5.2.3 Johnson & Johnson Monoclonal Antibody Drug Products, Services and Solutions
5.2.4 Johnson & Johnson Monoclonal Antibody Drug Revenue (US$ Million) & (2024-2024)
5.2.5 Johnson & Johnson Recent Developments
5.3 Roche
5.3.1 Roche Profile
5.3.2 Roche Main Business
5.3.3 Roche Monoclonal Antibody Drug Products, Services and Solutions
5.3.4 Roche Monoclonal Antibody Drug Revenue (US$ Million) & (2024-2024)
5.3.5 Ono Pharmaceutical Recent Developments
5.4 Ono Pharmaceutical
5.4.1 Ono Pharmaceutical Profile
5.4.2 Ono Pharmaceutical Main Business
5.4.3 Ono Pharmaceutical Monoclonal Antibody Drug Products, Services and Solutions
5.4.4 Ono Pharmaceutical Monoclonal Antibody Drug Revenue (US$ Million) & (2024-2024)
5.4.5 Ono Pharmaceutical Recent Developments
5.5 Amgen
5.5.1 Amgen Profile
5.5.2 Amgen Main Business
5.5.3 Amgen Monoclonal Antibody Drug Products, Services and Solutions
5.5.4 Amgen Monoclonal Antibody Drug Revenue (US$ Million) & (2024-2024)
5.5.5 Amgen Recent Developments
5.6 Merck
5.6.1 Merck Profile
5.6.2 Merck Main Business
5.6.3 Merck Monoclonal Antibody Drug Products, Services and Solutions
5.6.4 Merck Monoclonal Antibody Drug Revenue (US$ Million) & (2024-2024)
5.6.5 Merck Recent Developments
5.7 Jiangsu Hengrui Pharmaceuticals
5.7.1 Jiangsu Hengrui Pharmaceuticals Profile
5.7.2 Jiangsu Hengrui Pharmaceuticals Main Business
5.7.3 Jiangsu Hengrui Pharmaceuticals Monoclonal Antibody Drug Products, Services and Solutions
5.7.4 Jiangsu Hengrui Pharmaceuticals Monoclonal Antibody Drug Revenue (US$ Million) & (2024-2024)
5.7.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
5.8 Beigene
5.8.1 Beigene Profile
5.8.2 Beigene Main Business
5.8.3 Beigene Monoclonal Antibody Drug Products, Services and Solutions
5.8.4 Beigene Monoclonal Antibody Drug Revenue (US$ Million) & (2024-2024)
5.8.5 Beigene Recent Developments
5.9 Shanghai Junshi Biosciences
5.9.1 Shanghai Junshi Biosciences Profile
5.9.2 Shanghai Junshi Biosciences Main Business
5.9.3 Shanghai Junshi Biosciences Monoclonal Antibody Drug Products, Services and Solutions
5.9.4 Shanghai Junshi Biosciences Monoclonal Antibody Drug Revenue (US$ Million) & (2024-2024)
5.9.5 Shanghai Junshi Biosciences Recent Developments
5.10 Innovent Biologics
5.10.1 Innovent Biologics Profile
5.10.2 Innovent Biologics Main Business
5.10.3 Innovent Biologics Monoclonal Antibody Drug Products, Services and Solutions
5.10.4 Innovent Biologics Monoclonal Antibody Drug Revenue (US$ Million) & (2024-2024)
5.10.5 Innovent Biologics Recent Developments
5.11 WuXi Biologics (Cayman)
5.11.1 WuXi Biologics (Cayman) Profile
5.11.2 WuXi Biologics (Cayman) Main Business
5.11.3 WuXi Biologics (Cayman) Monoclonal Antibody Drug Products, Services and Solutions
5.11.4 WuXi Biologics (Cayman) Monoclonal Antibody Drug Revenue (US$ Million) & (2024-2024)
5.11.5 WuXi Biologics (Cayman) Recent Developments
5.12 Shanghai Henlius Biotech
5.12.1 Shanghai Henlius Biotech Profile
5.12.2 Shanghai Henlius Biotech Main Business
5.12.3 Shanghai Henlius Biotech Monoclonal Antibody Drug Products, Services and Solutions
5.12.4 Shanghai Henlius Biotech Monoclonal Antibody Drug Revenue (US$ Million) & (2024-2024)
5.12.5 Shanghai Henlius Biotech Recent Developments
5.13 Akeso
5.13.1 Akeso Profile
5.13.2 Akeso Main Business
5.13.3 Akeso Monoclonal Antibody Drug Products, Services and Solutions
5.13.4 Akeso Monoclonal Antibody Drug Revenue (US$ Million) & (2024-2024)
5.13.5 Akeso Recent Developments
5.14 Lepu Biopharma
5.14.1 Lepu Biopharma Profile
5.14.2 Lepu Biopharma Main Business
5.14.3 Lepu Biopharma Monoclonal Antibody Drug Products, Services and Solutions
5.14.4 Lepu Biopharma Monoclonal Antibody Drug Revenue (US$ Million) & (2024-2024)
5.14.5 Lepu Biopharma Recent Developments
5.15 CStone Pharmaceuticals
5.15.1 CStone Pharmaceuticals Profile
5.15.2 CStone Pharmaceuticals Main Business
5.15.3 CStone Pharmaceuticals Monoclonal Antibody Drug Products, Services and Solutions
5.15.4 CStone Pharmaceuticals Monoclonal Antibody Drug Revenue (US$ Million) & (2024-2024)
5.15.5 CStone Pharmaceuticals Recent Developments
5.16 Hillhouse Investment Management
5.16.1 Hillhouse Investment Management Profile
5.16.2 Hillhouse Investment Management Main Business
5.16.3 Hillhouse Investment Management Monoclonal Antibody Drug Products, Services and Solutions
5.16.4 Hillhouse Investment Management Monoclonal Antibody Drug Revenue (US$ Million) & (2024-2024)
5.16.5 Hillhouse Investment Management Recent Developments
5.17 Alphamab Oncology
5.17.1 Alphamab Oncology Profile
5.17.2 Alphamab Oncology Main Business
5.17.3 Alphamab Oncology Monoclonal Antibody Drug Products, Services and Solutions
5.17.4 Alphamab Oncology Monoclonal Antibody Drug Revenue (US$ Million) & (2024-2024)
5.17.5 Alphamab Oncology Recent Developments
5.18 Novartis
5.18.1 Novartis Profile
5.18.2 Novartis Main Business
5.18.3 Novartis Monoclonal Antibody Drug Products, Services and Solutions
5.18.4 Novartis Monoclonal Antibody Drug Revenue (US$ Million) & (2024-2024)
5.18.5 Novartis Recent Developments
5.19 Takeda Pharmaceutical
5.19.1 Takeda Pharmaceutical Profile
5.19.2 Takeda Pharmaceutical Main Business
5.19.3 Takeda Pharmaceutical Monoclonal Antibody Drug Products, Services and Solutions
5.19.4 Takeda Pharmaceutical Monoclonal Antibody Drug Revenue (US$ Million) & (2024-2024)
5.19.5 Takeda Pharmaceutical Recent Developments
6 North America
6.1 North America Monoclonal Antibody Drug Market Size by Country (2024-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Monoclonal Antibody Drug Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Monoclonal Antibody Drug Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Monoclonal Antibody Drug Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Monoclonal Antibody Drug Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Monoclonal Antibody Drug Market Dynamics
11.1 Monoclonal Antibody Drug Industry Trends
11.2 Monoclonal Antibody Drug Market Drivers
11.3 Monoclonal Antibody Drug Market Challenges
11.4 Monoclonal Antibody Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Monoclonal Antibody Drug Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Monoclonal Antibody Drug Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Monoclonal Antibody Drug Market Size Share by Region (2024-2024)
Table 4. Global Monoclonal Antibody Drug Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Monoclonal Antibody Drug Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Monoclonal Antibody Drug Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Monoclonal Antibody Drug Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Monoclonal Antibody Drug Revenue Market Share by Type (2024-2024)
Table 9. Global Monoclonal Antibody Drug Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Monoclonal Antibody Drug Revenue Market Share by Type (2024-2034)
Table 11. North America Monoclonal Antibody Drug Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Monoclonal Antibody Drug Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Monoclonal Antibody Drug Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Monoclonal Antibody Drug Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Monoclonal Antibody Drug Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Monoclonal Antibody Drug Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Monoclonal Antibody Drug Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Monoclonal Antibody Drug Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Monoclonal Antibody Drug Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Monoclonal Antibody Drug Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Monoclonal Antibody Drug Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Monoclonal Antibody Drug Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Monoclonal Antibody Drug Revenue Market Share by Application (2024-2024)
Table 24. Global Monoclonal Antibody Drug Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Monoclonal Antibody Drug Revenue Market Share by Application (2024-2034)
Table 26. North America Monoclonal Antibody Drug Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Monoclonal Antibody Drug Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Monoclonal Antibody Drug Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Monoclonal Antibody Drug Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Monoclonal Antibody Drug Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Monoclonal Antibody Drug Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Monoclonal Antibody Drug Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Monoclonal Antibody Drug Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Monoclonal Antibody Drug Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Monoclonal Antibody Drug Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Monoclonal Antibody Drug Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Monoclonal Antibody Drug Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Monoclonal Antibody Drug as of 2022)
Table 39. Date of Key Players Enter into Monoclonal Antibody Drug Market
Table 40. Global Monoclonal Antibody Drug Key Players Headquarters and Area Served
Table 41. Monoclonal Antibody Drug Product Solution and Service
Table 42. Global Monoclonal Antibody Drug Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Abbott Basic Information List
Table 45. Abbott Description and Business Overview
Table 46. Abbott Monoclonal Antibody Drug Products, Services and Solutions
Table 47. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Abbott (2024-2024)
Table 48. Abbott Recent Developments
Table 49. Johnson & Johnson Basic Information List
Table 50. Johnson & Johnson Description and Business Overview
Table 51. Johnson & Johnson Monoclonal Antibody Drug Products, Services and Solutions
Table 52. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Johnson & Johnson (2024-2024)
Table 53. Johnson & Johnson Recent Developments
Table 54. Roche Basic Information List
Table 55. Roche Description and Business Overview
Table 56. Roche Monoclonal Antibody Drug Products, Services and Solutions
Table 57. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Roche (2024-2024)
Table 58. Roche Recent Developments
Table 59. Ono Pharmaceutical Basic Information List
Table 60. Ono Pharmaceutical Description and Business Overview
Table 61. Ono Pharmaceutical Monoclonal Antibody Drug Products, Services and Solutions
Table 62. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Ono Pharmaceutical (2024-2024)
Table 63. Ono Pharmaceutical Recent Developments
Table 64. Amgen Basic Information List
Table 65. Amgen Description and Business Overview
Table 66. Amgen Monoclonal Antibody Drug Products, Services and Solutions
Table 67. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Amgen (2024-2024)
Table 68. Amgen Recent Developments
Table 69. Merck Basic Information List
Table 70. Merck Description and Business Overview
Table 71. Merck Monoclonal Antibody Drug Products, Services and Solutions
Table 72. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Merck (2024-2024)
Table 73. Merck Recent Developments
Table 74. Jiangsu Hengrui Pharmaceuticals Basic Information List
Table 75. Jiangsu Hengrui Pharmaceuticals Description and Business Overview
Table 76. Jiangsu Hengrui Pharmaceuticals Monoclonal Antibody Drug Products, Services and Solutions
Table 77. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Jiangsu Hengrui Pharmaceuticals (2024-2024)
Table 78. Jiangsu Hengrui Pharmaceuticals Recent Developments
Table 79. Beigene Basic Information List
Table 80. Beigene Description and Business Overview
Table 81. Beigene Monoclonal Antibody Drug Products, Services and Solutions
Table 82. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Beigene (2024-2024)
Table 83. Beigene Recent Developments
Table 84. Shanghai Junshi Biosciences Basic Information List
Table 85. Shanghai Junshi Biosciences Description and Business Overview
Table 86. Shanghai Junshi Biosciences Monoclonal Antibody Drug Products, Services and Solutions
Table 87. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Shanghai Junshi Biosciences (2024-2024)
Table 88. Shanghai Junshi Biosciences Recent Developments
Table 89. Innovent Biologics Basic Information List
Table 90. Innovent Biologics Description and Business Overview
Table 91. Innovent Biologics Monoclonal Antibody Drug Products, Services and Solutions
Table 92. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Innovent Biologics (2024-2024)
Table 93. Innovent Biologics Recent Developments
Table 94. WuXi Biologics (Cayman) Basic Information List
Table 95. WuXi Biologics (Cayman) Description and Business Overview
Table 96. WuXi Biologics (Cayman) Monoclonal Antibody Drug Products, Services and Solutions
Table 97. Revenue (US$ Million) in Monoclonal Antibody Drug Business of WuXi Biologics (Cayman) (2024-2024)
Table 98. WuXi Biologics (Cayman) Recent Developments
Table 99. Shanghai Henlius Biotech Basic Information List
Table 100. Shanghai Henlius Biotech Description and Business Overview
Table 101. Shanghai Henlius Biotech Monoclonal Antibody Drug Products, Services and Solutions
Table 102. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Shanghai Henlius Biotech (2024-2024)
Table 103. Shanghai Henlius Biotech Recent Developments
Table 104. Akeso Basic Information List
Table 105. Akeso Description and Business Overview
Table 106. Akeso Monoclonal Antibody Drug Products, Services and Solutions
Table 107. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Akeso (2024-2024)
Table 108. Akeso Recent Developments
Table 109. Lepu Biopharma Basic Information List
Table 110. Lepu Biopharma Description and Business Overview
Table 111. Lepu Biopharma Monoclonal Antibody Drug Products, Services and Solutions
Table 112. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Lepu Biopharma (2024-2024)
Table 113. Lepu Biopharma Recent Developments
Table 114. CStone Pharmaceuticals Basic Information List
Table 115. CStone Pharmaceuticals Description and Business Overview
Table 116. CStone Pharmaceuticals Monoclonal Antibody Drug Products, Services and Solutions
Table 117. Revenue (US$ Million) in Monoclonal Antibody Drug Business of CStone Pharmaceuticals (2024-2024)
Table 118. CStone Pharmaceuticals Recent Developments
Table 119. Hillhouse Investment Management Basic Information List
Table 120. Hillhouse Investment Management Description and Business Overview
Table 121. Hillhouse Investment Management Monoclonal Antibody Drug Products, Services and Solutions
Table 122. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Hillhouse Investment Management (2024-2024)
Table 123. Hillhouse Investment Management Recent Developments
Table 124. Alphamab Oncology Basic Information List
Table 125. Alphamab Oncology Description and Business Overview
Table 126. Alphamab Oncology Monoclonal Antibody Drug Products, Services and Solutions
Table 127. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Alphamab Oncology (2024-2024)
Table 128. Alphamab Oncology Recent Developments
Table 129. Novartis Basic Information List
Table 130. Novartis Description and Business Overview
Table 131. Novartis Monoclonal Antibody Drug Products, Services and Solutions
Table 132. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Novartis (2024-2024)
Table 133. Novartis Recent Developments
Table 134. Takeda Pharmaceutical Basic Information List
Table 135. Takeda Pharmaceutical Description and Business Overview
Table 136. Takeda Pharmaceutical Monoclonal Antibody Drug Products, Services and Solutions
Table 137. Revenue (US$ Million) in Monoclonal Antibody Drug Business of Takeda Pharmaceutical (2024-2024)
Table 138. Takeda Pharmaceutical Recent Developments
Table 139. North America Monoclonal Antibody Drug Market Size by Country (2024-2024) & (US$ Million)
Table 140. North America Monoclonal Antibody Drug Market Size by Country (2024-2034) & (US$ Million)
Table 141. Europe Monoclonal Antibody Drug Market Size by Country (2024-2024) & (US$ Million)
Table 142. Europe Monoclonal Antibody Drug Market Size by Country (2024-2034) & (US$ Million)
Table 143. Asia-Pacific Monoclonal Antibody Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 144. Asia-Pacific Monoclonal Antibody Drug Market Size by Region (2024-2024) & (US$ Million)
Table 145. Asia-Pacific Monoclonal Antibody Drug Market Size by Region (2024-2034) & (US$ Million)
Table 146. Asia-Pacific Monoclonal Antibody Drug Market Share by Region (2024-2024)
Table 147. Asia-Pacific Monoclonal Antibody Drug Market Share by Region (2024-2034)
Table 148. Latin America Monoclonal Antibody Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 149. Latin America Monoclonal Antibody Drug Market Size by Country (2024-2024) & (US$ Million)
Table 150. Latin America Monoclonal Antibody Drug Market Size by Country (2024-2034) & (US$ Million)
Table 151. Middle East & Africa Monoclonal Antibody Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 152. Middle East & Africa Monoclonal Antibody Drug Market Size by Country (2024-2024) & (US$ Million)
Table 153. Middle East & Africa Monoclonal Antibody Drug Market Size by Country (2024-2034) & (US$ Million)
Table 154. Monoclonal Antibody Drug Market Trends
Table 155. Monoclonal Antibody Drug Market Drivers
Table 156. Monoclonal Antibody Drug Market Challenges
Table 157. Monoclonal Antibody Drug Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Monoclonal Antibody Drug Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Monoclonal Antibody Drug Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Monoclonal Antibody Drug Market Share by Regions: 2022 VS 2034
Figure 4. Global Monoclonal Antibody Drug Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Monoclonal Antibody Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Monoclonal Antibody Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Monoclonal Antibody Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Monoclonal Antibody Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Monoclonal Antibody Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Humanized Monoclonal Antibody Drugs
Figure 11. Global Humanized Monoclonal Antibody Drugs Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Fully Human Monoclonal Antibody Drugs
Figure 13. Global Fully Human Monoclonal Antibody Drugs Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Small Molecule Antibody Drugs
Figure 15. Global Small Molecule Antibody Drugs Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Product Picture of Chimeric Monoclonal Antibody Drugs
Figure 17. Global Chimeric Monoclonal Antibody Drugs Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 18. Product Picture of Other
Figure 19. Global Other Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 20. Global Monoclonal Antibody Drug Market Size Share by Type: 2022 & 2034
Figure 21. North America Monoclonal Antibody Drug Revenue Market Share by Type (2024-2034)
Figure 22. Europe Monoclonal Antibody Drug Revenue Market Share by Type (2024-2034)
Figure 23. Asia-Pacific Monoclonal Antibody Drug Revenue Market Share by Type (2024-2034)
Figure 24. Latin America Monoclonal Antibody Drug Revenue Market Share by Type (2024-2034)
Figure 25. Middle East and Africa Monoclonal Antibody Drug Revenue Market Share by Type (2024-2034)
Figure 26. Cancer Treatment Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 27. Autoimmune Disease Treatment Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 28. Global Monoclonal Antibody Drug Market Size Share by Application: 2022 & 2034
Figure 29. North America Monoclonal Antibody Drug Revenue Market Share by Application (2024-2034)
Figure 30. Europe Monoclonal Antibody Drug Revenue Market Share by Application (2024-2034)
Figure 31. Asia-Pacific Monoclonal Antibody Drug Revenue Market Share by Application (2024-2034)
Figure 32. Latin America Monoclonal Antibody Drug Revenue Market Share by Application (2024-2034)
Figure 33. Middle East and Africa Monoclonal Antibody Drug Revenue Market Share by Application (2024-2034)
Figure 34. Monoclonal Antibody Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 35. Global Top 5 and Top 10 Players Monoclonal Antibody Drug Market Share in 2022
Figure 36. North America Monoclonal Antibody Drug Market Share by Country (2024-2034)
Figure 37. United States Monoclonal Antibody Drug Market Size (2024-2034) & (US$ Million)
Figure 38. Canada Monoclonal Antibody Drug Market Size (2024-2034) & (US$ Million)
Figure 39. Germany Monoclonal Antibody Drug Market Size (2024-2034) & (US$ Million)
Figure 40. France Monoclonal Antibody Drug Market Size (2024-2034) & (US$ Million)
Figure 41. U.K. Monoclonal Antibody Drug Market Size (2024-2034) & (US$ Million)
Figure 42. Italy Monoclonal Antibody Drug Market Size (2024-2034) & (US$ Million)
Figure 43. Russia Monoclonal Antibody Drug Market Size (2024-2034) & (US$ Million)
Figure 44. Nordic Countries Monoclonal Antibody Drug Market Size (2024-2034) & (US$ Million)
Figure 45. Asia-Pacific Monoclonal Antibody Drug Market Share by Region (2024-2034)
Figure 46. China Monoclonal Antibody Drug Market Size (2024-2034) & (US$ Million)
Figure 47. Japan Monoclonal Antibody Drug Market Size (2024-2034) & (US$ Million)
Figure 48. South Korea Monoclonal Antibody Drug Market Size (2024-2034) & (US$ Million)
Figure 49. Southeast Asia Monoclonal Antibody Drug Market Size (2024-2034) & (US$ Million)
Figure 50. India Monoclonal Antibody Drug Market Size (2024-2034) & (US$ Million)
Figure 51. Australia Monoclonal Antibody Drug Market Size (2024-2034) & (US$ Million)
Figure 52. Latin America Monoclonal Antibody Drug Market Share by Country (2024-2034)
Figure 53. Mexico Monoclonal Antibody Drug Market Size (2024-2034) & (US$ Million)
Figure 54. Brazil Monoclonal Antibody Drug Market Size (2024-2034) & (US$ Million)
Figure 55. Middle East & Africa Monoclonal Antibody Drug Market Share by Country (2024-2034)
Figure 56. Turkey Monoclonal Antibody Drug Market Size (2024-2034) & (US$ Million)
Figure 57. Saudi Arabia Monoclonal Antibody Drug Market Size (2024-2034) & (US$ Million)
Figure 58. UAE Monoclonal Antibody Drug Market Size (2024-2034) & (US$ Million)
Figure 59. Bottom-up and Top-down Approaches for This Report